Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240885 · ClinicalTrials.gov registry record
Metabolic and Functional Consequences of Aging in Health and Disease
A clinical trial of Aging, sponsored by Texas A&M University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05240885: Recruiting study of Aging, sponsored by Texas A&M University.
NCT05240885 is a study of Aging that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 100 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240885, a study of Aging, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Current knowledge of the aging experience and the trajectories of physical and cognitive decline across various age groups are not well-understood, yet crucial to prevent spending added years in disease. Hence, the study objective is to develop the metabolic profile associated with aging-related disorders measured as the incidence of impaired functional capacity, cognitive function, and/or well-being.
Primary Outcome
Whole-body production rate measured after stable tracer administration
Conditions Studied
Interventions
- OTHER Stable tracer infusion in a postabsorptive state
Study Locations (1)
Texas
- Human Clinical Research Building - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-04 |
| Est. Completion | 2026-09 |
What NCT05240885 shows while recruiting
NCT05240885 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Stable tracer infusion in a postabsorptive state is the first listed.
NCT05240885 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05240885 about?
NCT05240885 is a clinical study titled "Metabolic and Functional Consequences of Aging in Health and Disease". Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Cu...
What is the current status of trial NCT05240885?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-03-04. Estimated completion is 2026-09.
What conditions does trial NCT05240885 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT05240885?
The interventions under investigation include: Stable tracer infusion in a postabsorptive state (OTHER).
Who is sponsoring clinical trial NCT05240885?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240885 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240885's enrollment target sits among peer trials
100 87th of 262 higher than 166 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI